Skip to main content
SpringerLink
Log in

Posttransplant Management

  • Chapter
Cardiac Transplantation

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 172 Accesses

Abstract

The transition out of the operating room (OR) and into the intensive care unit (ICU) begins the process of caring for the newly transplanted heart. This chapter discusses two distinct aspects of this care: immediate postoperative management, where attention is directed to recovery from the operative procedure, and extended posttransplant care with a focus on immunosuppression, suggested biopsy regimens, and strategies to prevent transplant allograft vasculopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mets B, Michler RE, Delphin ED, et al. Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration. J Cardiothorac Vasc Anesth 1998; 12: 326–329.

    Article  PubMed  CAS  Google Scholar 

  2. Morales DLS, Gregg D, Heiman DN, et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg 2000; 69: 102–106.

    Article  PubMed  CAS  Google Scholar 

  3. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95: 1122–1125.

    Article  PubMed  CAS  Google Scholar 

  4. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588–595.

    Article  PubMed  CAS  Google Scholar 

  5. Anand IS, Ferrari R, Kalra GS, et al. Edema of cardiac origin. Circulation 1989; 80: 299–305.

    Article  PubMed  CAS  Google Scholar 

  6. Robertson GL. The regulation of vasopressin function in health and disease. Rec Prog Horm Res 1977; 33: 333–386.

    Google Scholar 

  7. Argenziano M, Chen JM, Cullinane S, et al. Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. J Heart Lung Transplant 1999; 18: 814–817.

    Article  PubMed  CAS  Google Scholar 

  8. Argenziano M, Choudhri AF, Oz MC, et al. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997;96(suppl 9):IL286-II.280.

    Google Scholar 

  9. Edwards RM, Rinza W, Kinter LB. Renal microvascular effects of vasopressin and vasopressin antagonist. Am J Physiol 1989; 256 (2 pt 2): F274 - F278.

    PubMed  CAS  Google Scholar 

  10. Hosenpud JD, Bennett LE, Berkeley MK, et al. The registry of the International Society for Heart and Lung Transplantation: 15th official report-1998. J Heart Lung Transplant 1998; 17: 656–668.

    PubMed  CAS  Google Scholar 

  11. Hosenpud JD, Novick RJ, Breen TJ, et al. The registry of the International Society for Heart and Lung Transplantation: 12th official report-1995. J Heart Lung Transplant 1995; 14: 805–815.

    PubMed  CAS  Google Scholar 

  12. Owen VJ, Burton PBJ, Michel MC, et al. Myocardial dysfunction in donor hearts: a possible etiology. Circulation 1999; 99: 2565–2570.

    Article  PubMed  CAS  Google Scholar 

  13. Kavarna MN, Sinha P, Eng M, et al. Mechanical support for the failing cardiac allograft: a single-center experience. J Heart Lung Transplant 2003; 22: 542–547.

    Article  Google Scholar 

  14. Mankad P, Yacoub M. Influence of basal release of nitric oxide on systolic and diastolic function of both ventricles. J Thorac Cardiovasc Surg 1997; 113: 770–776.

    Article  PubMed  CAS  Google Scholar 

  15. Ardehali A, Hughes K, Sadeghi A. et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation 2001; 72: 638–641.

    Article  PubMed  CAS  Google Scholar 

  16. Cui G, Tung T, Kobashigawa J, et al. Increased incidence of atrial flutter associated with the rejection of heart transplantation. Am J Cardiol 2001; 88: 280–284.

    Article  PubMed  CAS  Google Scholar 

  17. Magnano AR, Garan H. Catheter ablation of supraventricular tachycardia in the transplanted heart: a case series and literature review. Pacing Clin Electrophysiol 2003; 26: 1878–1886.

    Article  PubMed  Google Scholar 

  18. Chen JM, Hammond KM, Kherani AR, et al. Is the alternate waiting list too high risk? The Columbia-Presbyterian experience. J Heart Lung Transplant 2003; 1S: S175.

    Article  Google Scholar 

  19. Braith RW, Mills RM Jr., Wilcox CS, Davis GL, Wood CE. Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients. J Am Coll Cardiol 1996; 27: 375–383.

    Article  PubMed  CAS  Google Scholar 

  20. Braith RW, Mills RM, Wilcox CS, et al. High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients. J Am Coll Cardiol 2003; 41: 426–432.

    Article  PubMed  CAS  Google Scholar 

  21. Beniaminovitz A, Itescu S, Lietz K, et al. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med 2000; 342: 613–619.

    Article  PubMed  CAS  Google Scholar 

  22. Chan MCY, Kwok BW, Shiba B, et al. Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection. Transplant Proc 2002; 34: 1850–1852.

    Article  PubMed  CAS  Google Scholar 

  23. Taylor DO, Barr ML, Radovancevic B, et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999; 18: 336–345.

    Article  PubMed  CAS  Google Scholar 

  24. Reichart B, Meiser B, Vigano M, et al. European multicenter tacrolimus (FK506) heart pilot study: one-year results. J Heart Lung Transplant 1998; 17: 775–781.

    PubMed  CAS  Google Scholar 

  25. Kobashigawa J, Miller L, Renlund D, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation 1998; 66: 507–515.

    Article  PubMed  CAS  Google Scholar 

  26. DeNofrio D, Loh E, Kao A, et al. Mycophenolic acid concentrations are associated with cardiac allograft rejection. J Heart Lung Transplant 2000; 19: 1071–1076.

    Article  PubMed  CAS  Google Scholar 

  27. Shaw LM, Pawinski T, Korecka M, et al. Monitoring of mycophenolic acid in clinical transplantation. Ther Drug Monit 2002; 24: 68–73.

    Article  PubMed  CAS  Google Scholar 

  28. Marx S, Marks A. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 2001; 104: 852–855.

    Article  PubMed  CAS  Google Scholar 

  29. Eisen HJ, Tuzcu EM, Dorent R, et al. Efficacy and safety of everolimus as part of a triple immunosuppressive regimen in de novo cardiac transplant recipients: 12 month results. N Engl J Med 2003; 349: 847–858.

    Article  PubMed  CAS  Google Scholar 

  30. Mancini DM, Pinney SP, Burkhoff D, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003; 108: 48–53.

    Article  PubMed  CAS  Google Scholar 

  31. Lieberthal W, Fuhro R, Andry CC, et al. Rapamycin inhibits recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 2001; 28I: F693 - F706.

    Google Scholar 

  32. Mills RM, Naftel DC, Kirklin JK, et al. Heart transplant rejection with hemodynamic compromise: a multiinstituional study of the role of endomyocardial cellular infiltrate. J Heart Lung Transplant 1997; 16: 813–821.

    PubMed  CAS  Google Scholar 

  33. Kobashigawa JA, Kirklin JK, Naftel DC, et al. Pretransplant risk factors for acute rejection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1993; 12: 355–366.

    PubMed  CAS  Google Scholar 

  34. Kubo SH, Naftel DC, Mills RM Jr., et al. Risk factors for late recurrent rejection after heart transplantation: a multi-institutional, multivariable analysis. J Heart Lung Transplant 1995; 14: 409–418.

    PubMed  CAS  Google Scholar 

  35. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 1990; 9: 587–593.

    PubMed  CAS  Google Scholar 

  36. Olsen SL, Wagoner LE, Hammond EH, et al. Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations. J Heart Lung Transplant 1993; 12: S135 - S142.

    PubMed  CAS  Google Scholar 

  37. Grauhan O, Knosalla C, Ewert R, et al. Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation. J Heart Lung Transplant 2001; 20: 316–321.

    Article  PubMed  CAS  Google Scholar 

  38. Aranda JM Jr., Scornik JC, Normann SJ, et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 2002; 73: 907–910.

    Article  PubMed  Google Scholar 

  39. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741–1751.

    Article  PubMed  CAS  Google Scholar 

  40. Miller LW, Naftel DC, Bourge RC, et al. Infection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1993; 13: 381–393.

    Google Scholar 

  41. Rubin RH. Infection in the organ transplant recipient. In: Rubin RH, Young LS, eds. Clinical approach to infection in the compromised host. 3rd ed. New York: Plenum Publishing, 1994: 629–705.

    Google Scholar 

  42. Merigan TC, Renlund DG, Keay S, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 1992; 326: 1182–1186.

    Article  PubMed  CAS  Google Scholar 

  43. Sia IG, Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev 2000; 13: 83–121.

    Article  PubMed  CAS  Google Scholar 

  44. McNamara D, DiS alvo T, Mathier M, et al. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. J Heart Lung Transplant 1996; 15: 506–515.

    Google Scholar 

  45. Valantine HA, Gao SZ, Menon SG, et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation 1999; 100: 61–66.

    Article  PubMed  CAS  Google Scholar 

  46. Craigen JL, Grundy JE. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or fosacarnet treatment. Transplantation 1996; 62: 1102–1108.

    Article  PubMed  CAS  Google Scholar 

  47. Costanzo M, Naftel D, Pritzker M, et al. Heart transplant coronary artery disease detected by coronary angiography: a multi-institutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant 1998; 17: 744–753.

    PubMed  CAS  Google Scholar 

  48. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145–153.

    Article  PubMed  CAS  Google Scholar 

  49. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333: 621–627.

    Article  PubMed  CAS  Google Scholar 

  50. Wenke K, Meiser B, Thiery J, et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 2003; 107: 93–97.

    Article  PubMed  CAS  Google Scholar 

  51. Katznelson S, Huang XM, Chia D, et al. The inhibitor effects of pravastatin on natural killer T-cell activity in vivo in cytotoxic T-lymphocyte activity in vitro. J Heart Lung Transplant 1998; 259: 414–419.

    Google Scholar 

  52. Data on file, International Society for Heart and Lung Transplantation, June 2003.

    Google Scholar 

Download references

Authors
  1. Sean P. Pinney MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiothoracic Surgery, University of Wisconsin, Madison, WI, USA

    Niloo M. Edwards MD

  2. Pediatric Cardiac Surgery, Division of Cardiothoracic Surgery, Department of Surgery, Columbia University College of Physicians & Surgeons, New York, NY, USA

    Jonathan M. Chen MD

  3. Division of Cardiothoracic Surgery, Department of Surgery, Columbia University College of Physicians & Surgeons, New York, NY, USA

    Pamela A. Mazzeo

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Pinney, S.P. (2004). Posttransplant Management. In: Edwards, N.M., Chen, J.M., Mazzeo, P.A. (eds) Cardiac Transplantation. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-758-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-758-1_7

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9853-0

  • Online ISBN: 978-1-59259-758-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation